Winter is flu season – could it be coronavirus season as well? The research is mixed, but other factors besides temperature and humidity have more to do with the spread of SARS-CoV-2.
Academic rigour, journalistic flair
Articles on SARS-CoV-2
Displaying 501 - 520 of 583 articles
Ever heard of 229E, OC43, NL63 and HKU1?
Two phrases you hear a lot these days are viral load and infectious dose. What do they mean? Do they reflect the severity of disease or whether someone will get severely ill? Two experts explain.
Some people’s immune systems aren’t able to stop foreign invaders, such as COVID-19, as well as the rest of the population. There are many reasons for this, including illness, medications and age.
Some of the false claims about coronavirus may be harmless. But others can be potentially dangerous.
Most people with coronavirus will recover but how long until you’re no longer infectious? Here’s what the science tells us so far.
When a new virus emerges and triggers a pandemic, it is important to trace its origins. Knowing more about how the virus jumped species in the first place can help curb future zoonotic diseases.
Africa is better prepared now to perform research in emerging infections than during the Ebola epidemics in West Africa.
University of Pittsburgh researchers are developing a vaccine patch for COVID-19 that is as easy to apply as a Band-Aid.
Australia is making good progress in flattening the curve, which will save our hospitals from being overwhelmed. But we still have to work out what comes next and how restrictions can be safely eased.
To boost your immune defenses against corona and other viruses, one of the most effective things you can do is maintain your natural circadian rhythms. Here’s how to do that.
For some diseases, the dose of virus a person is exposed to is directly linked to how severe the disease is.
Cooped up with a partner and nowhere to go to break it up? Coronavirus social distancing… or another day in retirement? Research on older couples holds tips for everyone else on how to deal.
The head lice drug Ivermectin has stopped SARS-CoV-2, the virus that causes COVID-19, from replicating in lab tests. But we don’t know if it will work as a treatment for people with coronavirus.
Because low-income settlements are unplanned, crowded and without sanitation, there are many viral infections that cause health problems.
The president promoted the combination of hydroxychloroquine and an antibiotic for treating COVID-19. But a new study suggests it provides no benefits.
A lockdown by itself is not a magic wand for fighting coronavirus.
The South African National Defence Force has suffered from terrible neglect over the past 25 years of democracy.
The new coronavirus, SARS-CoV-2, spreads faster than the H1N1 influenza virus and is much deadlier. SARS-CoV-2 is particularly skilled at keeping cells from calling out for help.
There are now dozens of test for COVID-19 with hundreds more awaiting the FDA’s authorization. So which test is best? Does anyone know?
Top contributors
-
Professor of Medicine, University of Virginia
-
Research associate, Warren Alpert Medical School, Brown University, Brown University
-
Associate Professor, Epidemiology, Deakin University
-
Dean Faculty of Health Sciences and Professor of Vaccinology at University of the Witwatersrand; and Director of the SAMRC Vaccines and Infectious Diseases Analytics Research Unit, University of the Witwatersrand
-
Vice-Chancellor's Research Fellow, School of Health and Biomedical Sciences, RMIT University
-
Professor of Global Biosecurity, NHMRC L3 Research Fellow, Head, Biosecurity Program, Kirby Institute, UNSW Sydney
-
Instructor of Human Immunology, Emory University
-
Postdoctoral Fellow in Virology, University of Colorado Boulder
-
Postdoctoral Fellow in Virology and Immunology, University of Colorado Boulder
-
Professor, Nursing, School of Nursing and Midwifery, Griffith University
-
Research Leader in Virology and Infectious Disease, Griffith University
-
Scientific Officer, University of Leeds
-
Lecturer in Virology, Queen's University Belfast
-
Professor of Molecular, Cellular and Developmental Biology, University of Colorado Boulder
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
